{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:57:35Z","timestamp":1764997055949},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.reuma.2015.10.010","type":"journal-article","created":{"date-parts":[[2015,12,25]],"date-time":"2015-12-25T05:00:23Z","timestamp":1451019623000},"page":"256-262","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain"],"prefix":"10.1016","volume":"12","author":[{"given":"Ra\u00fal","family":"Menor Almagro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Jurado Roger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"Rodr\u00edguez Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Sol\u00eds D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Humberto","family":"Cardiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Javier","family":"Salaberri Maestrojuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2015.10.010_bib0155","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI14452","article-title":"Autoantibodies as predictor of disease","volume":"108","author":"Leslie","year":"2001","journal-title":"J Clin Investig"},{"key":"10.1016\/j.reuma.2015.10.010_bib0160","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.autrev.2007.01.006","article-title":"Autoimmune as predictor of disease: the clinical and experimental evidence","volume":"6","author":"Bizarro","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.reuma.2015.10.010_bib0165","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/art.10561","article-title":"Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing","volume":"47","author":"Solomon","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2015.10.010_bib0170","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaut.2010.06.016","article-title":"B-cell epitopes of the intracellular autoantigens Ro\/SSA and anti-La\/SSB: tools to study the regulation of the autoimmune response","volume":"35","author":"Routsias","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.reuma.2015.10.010_bib0175","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.amjmed.2012.09.014","article-title":"The clinical utility of a positive antinuclear antibody test result","volume":"126","author":"Abeles","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.reuma.2015.10.010_bib0180","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.autrev.2010.09.005","article-title":"Clinical and laboratory aspects of Ro\/SSA-52 autoantibodies","volume":"10","author":"Defendenti","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.reuma.2015.10.010_bib0185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.autrev.2010.09.001","article-title":"The meaning of anti-Ro and anti-La antibodies in primary Sj\u00f6gren's syndrome","volume":"10","author":"Hernandez-Molina","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"2\u20133","key":"10.1016\/j.reuma.2015.10.010_bib0190","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12016-009-8152-z","article-title":"Sj\u00f6gren syndrome or sj\u00f6gren disease? The histological and immunological bias caused by the 2002 criteria","volume":"38","author":"Ramos-Casals","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.reuma.2015.10.010_bib0195","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","article-title":"Primary Sj\u00f6gren syndrome in Spain: clinical and immunologic expression in 1010 patients","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.reuma.2015.10.010_bib0200","first-page":"520","article-title":"Anti-SSA\/Ro and anti-SSB\/anti-La antibodies. What's new?","volume":"153","author":"Meyer","year":"2002","journal-title":"Ann Med Interne (Par\u00eds)"},{"key":"10.1016\/j.reuma.2015.10.010_bib0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/08916930400022954","article-title":"Anti-Ro\/SSA and anti-La\/SSB antibodies","volume":"38","author":"Franceschini","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.reuma.2015.10.010_bib0210","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.autrev.2004.12.002","volume":"4","author":"Locht","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.reuma.2015.10.010_bib0215","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/ar3787","article-title":"Congenital heart block: evidence for a pathogenic role of maternal antibodies","volume":"14","author":"Ambrosi","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.reuma.2015.10.010_bib0220","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","article-title":"The clinical spectrum of autoimmune congenital heart block","volume":"11","author":"Brito-Zer\u00f3n","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.reuma.2015.10.010_bib0225","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00296-010-1790-x","article-title":"The prevalence and the clinical relevance of anti-Ro52 in Korean patients with primary Sj\u00f6gren's syndrome","volume":"32","author":"Song","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.reuma.2015.10.010_sbref0230a","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/rheumatology\/ket141","article-title":"Predicting Sj\u00f6gren syndromein patients with recent-onset SLE","volume":"52","author":"Hern\u00e1ndez Molina","year":"2013","journal-title":"Rheumatology (Oxf)"},{"key":"10.1016\/j.reuma.2015.10.010_sbref0230b","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.61.12.1090","article-title":"Diagnostic associations in a large and consecutively identified population positive for anti-SSA and\/or anti-SSB: the range of associated diseases differs according to the detailed serotype","volume":"61","author":"Peene","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2015.10.010_bib0235","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.61.12.1090","article-title":"Diagnostic associations in a large and consecutively identified population positive for anti-SSA and\/or anti-SSB: the range of associated diseases differs according to the detailed serotype","volume":"61","author":"Peene","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2015.10.010_bib0240","first-page":"579","article-title":"Clinical optimization and multicenter validation of antigen-specific cut-off values on the INNO-LIA ANA update for the detection of autoantibodies in connective tissue disorders","volume":"22","author":"Pottel","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reuma.2015.10.010_bib0245","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1196\/annals.1313.035","article-title":"Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases","volume":"1050","author":"Eissfeller","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.reuma.2015.10.010_bib0250","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1191\/0961203303lu439oa","article-title":"Simultaneous identification of various antinuclear antibodies using an automated","volume":"12","author":"L\u00f3pez-Longo","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.reuma.2015.10.010_bib0255","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1196\/annals.1313.023","article-title":"Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease","volume":"1050","author":"Lyons","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.reuma.2015.10.010_bib0260","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar3763","article-title":"Clinical significance of autoantibodies to R52\/TRIM21 in systemic sclerosis","volume":"14","author":"Hudson","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.reuma.2015.10.010_bib0265","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.autrev.2011.03.004","article-title":"Clinical significance of anti-anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study","volume":"10","author":"Ghillani","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.reuma.2015.10.010_bib0270","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/ard.61.10.929","article-title":"Anti-anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease","volume":"61","author":"Peene","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2015.10.010_bib0275","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.autrev.2009.02.010","article-title":"Latest update on the Ro\/SS-A autoantibody system. Latest update on the Ro\/SS-A autoantibody system","volume":"8","author":"Schulte-Pelkum","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.reuma.2015.10.010_bib0280","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0961203306073135","article-title":"Fine specificity of the Ro\/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun","volume":"16","author":"Popovic","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.reuma.2015.10.010_bib0285","first-page":"686","article-title":"Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sj\u00f6gren's syndrome","volume":"30","author":"Retamozo","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reuma.2015.10.010_bib0290","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/08916930008994077","article-title":"Comparison of the anti-Ro\/SSA autoantibody profile between patients with primary and secondary Sj\u00f6gren's syndrome","volume":"32","author":"G\u00e1l","year":"2000","journal-title":"Autoimmunity"},{"key":"10.1016\/j.reuma.2015.10.010_bib0295","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1136\/ard.2009.127100","article-title":"ANA screening: an old test with new recommendations","volume":"69","author":"Meroni","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2015.10.010_bib0300","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/BOR.0000000000000096","article-title":"Advances in the understanding and treatment of systemic complications in Sj\u00f6gren's syndrome","volume":"26","author":"Brito-Zer\u00f3n","year":"2014","journal-title":"Curr Opin Rheumatol"}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X15001849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X15001849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T23:35:29Z","timestamp":1567467329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X15001849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1699258X15001849"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2015.10.010","relation":{},"ISSN":["1699-258X"],"issn-type":[{"type":"print","value":"1699-258X"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2015.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}